ArticleAnnals of translational medicine2022
PCSK9 inhibitor inclisiran for treating atherosclerosis via regulation of endothelial cell pyroptosis.
Ni Kong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this paperpooled itcites it